Search Within

Hugo Castro-Malaspina

Formats
  1. Meeting Abstract (212)
  2. Journal Article (111)
  3. Conference Paper (8)
  4. Research Letter (2)
Groups
  1. Bone Marrow Transplant (333)
  2. Center for Hematologic Malignancies (333)
  3. Department of Medicine (333)
  4. Hematologic Malignancies, Division of (333)
  5. Sloan Kettering Institute Faculty (212)
  6. Pediatrics, Department of (210)

More Groups

People
  1. Esperanza Papadopoulos (211)
  2. Miguel-Angel Perales (187)
  3. Ann Jakubowski (185)
  4. Richard O'Reilly (184)
  5. Sergio Giralt (164)
  6. James Young (157)

More People

Years
  1. 2023 (1)
  2. 2022 (4)
  3. 2021 (4)
  4. 2020 (8)
  5. 2019 (13)
  6. 2018 (23)

More Years

Publications
  1. Blood (134)
  2. Biology of Blood and Marrow Transplantation (97)
  3. Bone Marrow Transplantation (34)
  4. Experimental Hematology (9)
  5. British Journal of Haematology (6)
  6. Journal of Clinical Oncology (5)

More Publications

Publishers
  1. American Society of Hematology (136)
  2. Elsevier Inc. (106)
  3. Nature Publishing Group (35)
  4. Elsevier Science, Inc. (11)
  5. John Wiley & Sons (8)
  6. American Society of Clinical Oncology (5)

More Publishers

Results (333)


Citation style sort is year ascending, and then by author or title. Author ascending is default.
  • Response to immunizations following allogeneic HCT with adjuvant rituximab therapy
    Meeting Abstract

    Pao, M.; Papadopoulos, E. B.; Boulad, F.; Castro-Malaspina, H.; Jakubowski, A.; Kernan, N. A.; Perales, M.; Prockop, S.; Ford, R.; Young, J. W.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Results of T cell depleted (TCD) myeloablative hematopoietic stem cell transplants (HSCT) in patients with hematologic malignancies >= 55 yrs of age
    Meeting Abstract

    Jakubowski, A. A.; Papadopoulos, E. B.; Castro-Malaspina, H. R.; Hsu, K.; Perales, M. A.; Van Den Brink, M.; Young, J. W.; O'Reilly, R. J.
    Blood (2005)

    Fulltext@MSK | Save
  • Fludarabine-based conditioning secures engraftment of secondary hematopoietic stem cell allografts (HSCT) used to treat graft failure
    Meeting Abstract

    Chewning, J. H.; Castro-Malaspina, H. R.; Hsu, K.; Jakubowski, A. A.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M. A.; Prockop, S. E.; Small, T. N.; van den Brink, M. R. M.; more...
    Biology of Blood and Marrow Transplantation (2005)

    Fulltext@MSK | Save
  • Induction of remission prior to transplantation improves the disease-free survival (DFS) of patients with advanced myelodysplastic syndromes (MDS) treated with myeloablative T-cell depleted (TCD) stem cell transplants (SCT) from HLA identical siblings
    Meeting Abstract

    Castro-Malaspina, H. R.; Jakubowski, A. A.; Papadopoulos, E. B.; Boulad, F.; Young, J. W.; Kernan, N. A.; Perales, M. A.; Small, T. N.; Hsu, K. C.; Chiu, M.; more...
    Blood (2005)

    Fulltext@MSK | Save
  • Frequency of molecular and PET/CT complete remissions in patients with multiple myeloma after autologous followed by reduced-intensity allogeneic stem cell transplants
    Meeting Abstract

    Zhou, P.; Castro-Malaspina, H.; Papadopoulos, E. B.; Young, J. W.; Miller, K.; Pandit-Taskar, N.; Filippa, D. A.; Fleisher, M.; Comenzo, R. L.
    Blood (2004)

    Fulltext@MSK | Save
  • Vaccine reponses following unmodified or T cell depleted unrelated and mismatched related HCT
    Meeting Abstract

    Small, T. N.; Papadopoulos, E. B.; Boulad, F.; Kernan, N. A.; Ford, R.; Taylor, J.; Casson, A.; Torok-Castanza, J.; Cuello, B.; Young, J. W.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • A phase II trial of a non-myeloablative regimen combining in vivo T cell depletion with an anti-CD52 monoclonal antibody (alemtuzumab), and chemotherapy with fludarabine and melphalan prior to a related or unrelated hematopoietic stem cell transplantation
    Meeting Abstract

    Castro-Malaspina, H.; Papadopoulos, E.; Jakubowski, A.; Perales, M. A.; Young, J.; Hsu, K.; Boulad, F.; Prasad, V.; Small, T.; Kernan, N.; more...
    Biology of Blood and Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • A phase II trial of busulfan, melphalan, and fludarabine followed by allogeneic T-cell depleted hematopoietic stem cell transplants from HLA-identical, or HLA-non identical related or unrelated donors for the treatment of advanced hematopoietic malignancies
    Meeting Abstract

    Boulad, F.; Jakubowski, A.; Castro-Malaspina, H.; Hsu, K. C.; Kernan, N. A.; Papadopoulos, E. B.; Perales, M. A.; Prockop, S. E.; Small, T. N.; van den Brink, M. R. M.; more...
    Blood (2004)

    Fulltext@MSK | Save
  • Treatment of menorrhagia in women undergoing hematopoietic stem cell transplantation
    Journal Article

    Amsterdam, A.; Jakubowski, A.; Castro-Malaspina, H.; Baxi, E.; Kauff, N.; Krychman, M.; Stier, E.; Castiel, M.
    Bone Marrow Transplantation (2004)

    Fulltext@MSK | Save
  • Sustained complete remission of CLL associated with the use of a Chinese herbal extract: Case report and mechanistic analysis
    Journal Article

    Battle, T. E.; Castro-Malaspina, H.; Gribben, J. G.; Frank, D. A.
    Leukemia Research (2003)

    Fulltext@MSK | Save